{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:00:11Z","timestamp":1790532011991,"version":"4.1.0"},"reference-count":42,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:00:00Z","timestamp":1620950400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81371821"],"award-info":[{"award-number":["81371821"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation Project of Shanghai","award":["19ZR1407800"],"award-info":[{"award-number":["19ZR1407800"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatic fibrosis is a common response to chronic liver injury. Recently, the role of DZNep (a histone methyltransferase EZH2 inhibitor) in repressing pulmonary and renal fibrosis was verified. However, the potential effect of DZNep on hepatic fibrosis has not been elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The hepatic fibrosis model was established in rats treated with CCl4 and in hepatic stellate cells (HSCs) treated with TGF-\n                      <jats:italic>\u03b2<\/jats:italic>\n                      1. The liver tissues were stained with H&amp;E and Masson\u2019s trichrome. The expression of EZH2, SOCS7, collagen I,\n                      <jats:italic>\u03b1<\/jats:italic>\n                      SMA mRNA and miR-199-5p was assessed using qPCR, immunohistochemical or western blot analysis. A dual-luciferase reporter assay was carried out to validate the regulatory relationship of miR-199a-5p with SOCS7.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The EZH2 level was increased in CCl4-treated rats and in TGF-\n                      <jats:italic>\u03b2<\/jats:italic>\n                      1-treated HSCs, whereas DZNep treatment significantly inhibited EZH2 expression. DZNep repressed hepatic fibrosis in vivo and in vitro, as evidenced by the decrease of hepatic fibrosis markers (\n                      <jats:italic>\u03b1<\/jats:italic>\n                      -SMA and Collagen I). Moreover, miR-199a-5p expression was repressed by DZNep in TGF-\n                      <jats:italic>\u03b2<\/jats:italic>\n                      1-activated HSCs. Notably, downregulation of miR-199a-5p decreased TGF-\n                      <jats:italic>\u03b2<\/jats:italic>\n                      1-induced expression of fibrosis markers. SOCS7 was identified as a direct target of miR-199a-5p. The expression of SOCS7 was decreased in TGF-\n                      <jats:italic>\u03b2<\/jats:italic>\n                      1-activated HSCs, but DZNep treatment restore d SOCS7 expression. More importantly, SOCS7 knockdown decreased the effect of DZNep on collagen I and\n                      <jats:italic>\u03b1<\/jats:italic>\n                      SMA expression in TGF-\n                      <jats:italic>\u03b2<\/jats:italic>\n                      1-activated HSCs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>DZNep suppresses hepatic fibrosis through regulating miR-199a-5p\/SOCS7 axis, suggesting that DZNep may represent a novel treatment for fibrosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.7717\/peerj.11374","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:46:12Z","timestamp":1620967572000},"page":"e11374","source":"Crossref","is-referenced-by-count":14,"title":["DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p\/SOCS7 pathway"],"prefix":"10.7717","volume":"9","author":[{"given":"Rongrong","family":"Ding","sequence":"first","affiliation":[{"name":"Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China"},{"name":"Hepatobiliary Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Zheng","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Cheng","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Zhu","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Wang","sequence":"additional","affiliation":[{"name":"Hepatobiliary Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Hepatobiliary Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanqing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hepatobiliary Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangfeng","family":"Shi","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2021,5,14]]},"reference":[{"key":"10.7717\/peerj.11374\/ref-1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0092-8674(01)00616-X","article-title":"microRNAs: tiny regulators with great potential","volume":"107","author":"Ambros","year":"2001","journal-title":"Cell"},{"key":"10.7717\/peerj.11374\/ref-2","doi-asserted-by":"publisher","first-page":"e112384","DOI":"10.1371\/journal.pone.0112384","article-title":"Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repression","volume":"9","author":"Atta","year":"2014","journal-title":"PLOS ONE"},{"key":"10.7717\/peerj.11374\/ref-3","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1172\/JCI23853","article-title":"Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans","volume":"115","author":"Banks","year":"2005","journal-title":"Journal of Clinical Investigation"},{"key":"10.7717\/peerj.11374\/ref-4","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1073\/pnas.1702750114","article-title":"Small molecule-mediated inhibition of myofibroblast transdifferentiation for the treatment of fibrosis","volume":"114","author":"Bollong","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.7717\/peerj.11374\/ref-5","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/j.ajpath.2016.07.011","article-title":"Fibrogenic signaling is suppressed in hepatic stellate cells through targeting of connective tissue growth factor (CCN2) by cellular or exosomal MicroRNA-199a-5p","volume":"186","author":"Chen","year":"2016","journal-title":"American Journal of Pathology"},{"key":"10.7717\/peerj.11374\/ref-6","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1096\/fj.13-241760","article-title":"A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis","volume":"28","author":"Coward","year":"2014","journal-title":"FASEB Journal"},{"key":"10.7717\/peerj.11374\/ref-7","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.3389\/fmicb.2017.02431","article-title":"SOCS proteins as regulators of inflammatory responses induced by bacterial infections: a review","volume":"8","author":"Duncan","year":"2017","journal-title":"Frontiers in Microbiology"},{"key":"10.7717\/peerj.11374\/ref-8","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.tips.2019.03.001","article-title":"Targeting SOCS proteins to control JAK-STAT signalling in disease","volume":"40","author":"Durham","year":"2019","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.7717\/peerj.11374\/ref-9","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.jhep.2011.09.024","article-title":"Clinical evidence for the regression of liver fibrosis","volume":"56","author":"Ellis","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.7717\/peerj.11374\/ref-10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cell.2007.12.024","article-title":"Getting to the root of miRNA-mediated gene silencing","volume":"132","author":"Eulalio","year":"2008","journal-title":"Cell"},{"issue":"3","key":"10.7717\/peerj.11374\/ref-11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.hbpd.2018.04.003","article-title":"Hepatic fibrosis: it is time to go with hepatic stellate cell-specific therapeutic targets","volume":"17","author":"Ezhilarasan","year":"2018","journal-title":"Hepatobiliary & Pancreatic Diseases International"},{"key":"10.7717\/peerj.11374\/ref-12","doi-asserted-by":"publisher","first-page":"6895","DOI":"10.1038\/onc.2017.291","article-title":"Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA","volume":"36","author":"Feng","year":"2017","journal-title":"Oncogene"},{"issue":"9","key":"10.7717\/peerj.11374\/ref-13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41419-020-03014-7","article-title":"PTPN14 aggravates inflammation through promoting proteasomal degradation of SOCS7 in acute liver failure","volume":"11","author":"Fu","year":"2020","journal-title":"Cell Death & Disease"},{"key":"10.7717\/peerj.11374\/ref-14","doi-asserted-by":"crossref","first-page":"36436","DOI":"10.1038\/srep36436","article-title":"Interleukin-22 ameliorates liver fibrosis through miR-200a\/beta-catenin","volume":"6","author":"Hu","year":"2016","journal-title":"Scientific Reports"},{"key":"10.7717\/peerj.11374\/ref-15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.7150\/ijms.29930","article-title":"MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation","volume":"16","author":"Huang","year":"2019","journal-title":"International Journal of Medical Sciences"},{"key":"10.7717\/peerj.11374\/ref-16","doi-asserted-by":"publisher","first-page":"34436","DOI":"10.1038\/srep36436","article-title":"The roles of microRNA families in hepatic fibrosis","volume":"7","author":"Jiang","year":"2017","journal-title":"Cell & Bioscience"},{"key":"10.7717\/peerj.11374\/ref-17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/ng2003","article-title":"Impaired microRNA processing enhances cellular transformation and tumorigenesis","volume":"39","author":"Kumar","year":"2007","journal-title":"Nature Genetics"},{"key":"10.7717\/peerj.11374\/ref-18","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.ajpath.2017.06.014","article-title":"Epigenetic silencing of miRNA-34a in human cholangiocarcinoma via EZH2 and DNA methylation: impact on regulation of notch pathway","volume":"187","author":"Kwon","year":"2017","journal-title":"American Journal of Pathology"},{"key":"10.7717\/peerj.11374\/ref-19","doi-asserted-by":"publisher","first-page":"e15690","DOI":"10.1371\/journal.pone.0015690","article-title":"Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-\/- mice","volume":"5","author":"Latasa","year":"2010","journal-title":"PLOS ONE"},{"key":"10.7717\/peerj.11374\/ref-20","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1111\/j.1582-4934.2008.00513.x","article-title":"MicroRNAs in embryonic stem cells and early embryonic development","volume":"12","author":"Laurent","year":"2008","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.7717\/peerj.11374\/ref-21","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"10.7717\/peerj.11374\/ref-22","doi-asserted-by":"publisher","first-page":"e1003291","DOI":"10.1371\/journal.pgen.1003291","article-title":"miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1","volume":"9","author":"Lino\u00a0Cardenas","year":"2013","journal-title":"PLOS Genetics"},{"key":"10.7717\/peerj.11374\/ref-23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1750-3639.2007.00121.x","article-title":"MicroRNAs: biogenesis and molecular functions","volume":"18","author":"Liu","year":"2008","journal-title":"Brain Pathology"},{"key":"10.7717\/peerj.11374\/ref-24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jcmgh.2018.09.005","article-title":"Enhancer of zeste homologue 2 inhibition attenuates tgf-beta dependent hepatic stellate cell activation and liver fibrosis","volume":"7","author":"Martin-Mateos","year":"2019","journal-title":"Cellular and Molecular Gastroenterology and Hepatologyl Hepatol"},{"key":"10.7717\/peerj.11374\/ref-25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"10.7717\/peerj.11374\/ref-26","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/j.biochi.2013.09.003","article-title":"Wnt signaling in liver fibrosis: progress, challenges and potential directions","volume":"95","author":"Miao","year":"2013","journal-title":"Biochimie"},{"key":"10.7717\/peerj.11374\/ref-27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.molcel.2013.12.005","article-title":"The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing","volume":"53","author":"Mozzetta","year":"2014","journal-title":"Molecular Cell"},{"key":"10.7717\/peerj.11374\/ref-28","doi-asserted-by":"publisher","first-page":"e482","DOI":"10.1038\/cddis.2013.11","article-title":"socs7, a target gene of microRNA-145, regulates interferon-beta induction through STAT3 nuclear translocation in bladder cancer cells","volume":"4","author":"Noguchi","year":"2013","journal-title":"Cell Death & Disease"},{"key":"10.7717\/peerj.11374\/ref-29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13075-016-0929-x","article-title":"MicroRNAs in fibrosis: opportunities and challenges","volume":"18","author":"O\u2019Reilly","year":"2016","journal-title":"Arthritis Research & Therapy"},{"key":"10.7717\/peerj.11374\/ref-30","doi-asserted-by":"publisher","first-page":"e9022","DOI":"10.1371\/journal.pone.0009022","article-title":"MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation","volume":"5","author":"Ortega","year":"2010","journal-title":"PLOS ONE"},{"key":"10.7717\/peerj.11374\/ref-31","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/MNH.0b013e328354e559","article-title":"MicroRNAs and fibrosis","volume":"21","author":"Patel","year":"2012","journal-title":"Current Opinion in Nephrology and Hypertension"},{"key":"10.7717\/peerj.11374\/ref-32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nature Reviews Immunology"},{"key":"10.7717\/peerj.11374\/ref-33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.yjmcc.2019.08.003","article-title":"EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation","volume":"135","author":"Song","year":"2019","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.7717\/peerj.11374\/ref-34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11010-013-1895-0","article-title":"Participation of miR-200a in TGF-beta1-mediated hepatic stellate cell activation","volume":"388","author":"Sun","year":"2014","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.7717\/peerj.11374\/ref-35","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jhep.2015.03.039","article-title":"Mechanisms of liver fibrosis resolution","volume":"63","author":"Tacke","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.7717\/peerj.11374\/ref-36","first-page":"100","article-title":"Cirrhosis\u2013can we reverse hepatic fibrosis?","volume":"587","author":"Tangkijvanich","year":"2002","journal-title":"European Journal of Surgery. Supplement"},{"key":"10.7717\/peerj.11374\/ref-37","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1073\/pnas.1813006116","article-title":"Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma","volume":"116","author":"Tsou","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.7717\/peerj.11374\/ref-38","doi-asserted-by":"crossref","first-page":"12915","DOI":"10.14814\/phy2.12915","article-title":"EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis","volume":"4","author":"Xiao","year":"2016","journal-title":"Physiological Reports"},{"key":"10.7717\/peerj.11374\/ref-39","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1111\/jcmm.13153","article-title":"EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis","volume":"21","author":"Yang","year":"2017","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.7717\/peerj.11374\/ref-40","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ymthe.2016.10.004","article-title":"A proof-of-concept for epigenetic therapy of tissue fibrosis: inhibition of liver fibrosis progression by 3-deazaneplanocin A","volume":"25","author":"Zeybel","year":"2017","journal-title":"Molecular Therapy"},{"key":"10.7717\/peerj.11374\/ref-41","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1096\/fj.201901380RR","article-title":"Long noncoding RNA growth arrest-specific transcript 5 alleviates renal fibrosis in diabetic nephropathy by downregulating matrix metalloproteinase 9 through recruitment of enhancer of zeste homolog 2","volume":"34","author":"Zhang","year":"2020","journal-title":"FASEB Journal"},{"key":"10.7717\/peerj.11374\/ref-42","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.phrs.2017.10.013","article-title":"Carnosol-mediated Sirtuin 1 activation inhibits Enhancer of Zeste Homolog 2 to attenuate liver fibrosis","volume":"128","author":"Zhao","year":"2018","journal-title":"Pharmacological Research"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/11374.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/11374.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/11374.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/11374.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:46:23Z","timestamp":1620967583000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/11374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,14]]},"references-count":42,"alternative-id":["10.7717\/peerj.11374"],"URL":"https:\/\/doi.org\/10.7717\/peerj.11374","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.7287\/peerj.11374v0.2\/reviews\/2","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.11374v0.1\/reviews\/2","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.11374v0.1\/reviews\/1","asserted-by":"object"}]},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,14]]},"article-number":"e11374"}}